Other therapy.
Performance Characteristics of the BluePrint® Breast Cancer Diagnostic Test
PUBLICATION: Translational Oncology Volume 13, Issue 4, April 2020, 100756 Read More
Performance Characteristics of the BluePrint® Breast Cancer Diagnostic Test
Transl Oncol. 2020 Apr; 13(4): 100756 Authors: Lorenza Mittempergher, et al.
Read More
Miami Breast 2020 FLEX Trials in Progress
AUTHORS: Robert Maganini, Pond Kelemen, Jennifer A. Crozier, Gordan Srkalovic, Read More
SABCS 2019: FLEX Trials in Progress
AUTHORS: Jennifer Crozier, Gordan Srkalovic, Adam Brufsky, Mehran Habibi, Pat Read More
SABCS 2019: Chinese Patient Clinical Data
AUTHORS: Ava Kwong, Sarah Untch, Heather M. Kling, Christine Finn, Read More
SABCS 2019: FLEX African American Clinical Data
AUTHORS: Raquel Nunes, Dipali Sharma, Lisa E. Blumencranz, Heather M. Read More
ESMO Sept 30 Successful launch of the MammaPrint and BluePrint NGS
AUTHORS: Leonie JMJ Delahaye, Anke T Witteveen, Mireille HJ Snel1, Read More
ESMO Sept 29 Unravelling the biological characteristics of MammaPrint
AUTHORS Rajith Bhaskaran, Christian J Griffioen, Diedrik Wehkamp, Lorenza Mittempergher Read More
Decentralization of Next-Generation RNA Sequencing-Based MammaPrint® and BluePrint® Kit at University Hospitals Leuven and Curie Institute Paris.
PUBLICATION: Transl Oncol. 2019 Sep 9;12(12):1557-1565. doi: 10.1016/j.tranon.2019.08.008. AUTHORS: Slembrouck Read More
MammaPrint and BluePrint Molecular Diagnostics Using Targeted RNA Next-Generation Sequencing Technology
PUBLICATION: Journal of Molecular Diagnostics September 2019 Volume 21, Issue Read More
